Old Web
English
Sign In
Acemap
>
authorDetail
>
Catherine Germeau
Catherine Germeau
Université catholique de Louvain
Melanoma
CTL*
Antigen
Cytotoxic T cell
Virology
4
Papers
293
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.
2011
International Journal of Cancer
Wenbin Ma
Nathalie Vigneron
Jacques Chapiro
Vincent Stroobant
Catherine Germeau
Thierry Boon
Pierre Coulie
Benoît Van den Eynde
Show All
Source
Cite
Save
Citations (28)
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens
2005
Journal of Experimental Medicine
Catherine Germeau
Wenbin Ma
Francesca Schiavetti
Christophe Lurquin
Emmanuelle Henry
Nathalie Vigneron
Francis Brasseur
Bernard Lethe
Etienne De Plaen
Thierry Velu
Thierry Boon
Pierre Coulie
Show All
Source
Cite
Save
Citations (215)
Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2
2004
International Journal of Cancer
Wenbin Ma
Catherine Germeau
Nathalie Vigneron
Anne‐Sophie Maernoudt
Sandra Morel
Thierry Boon
Pierre Coulie
Benoît Van den Eynde
Show All
Source
Cite
Save
Citations (50)
Invited Lecture: Monitoring MAGE vaccination. Insights into mechanisms of tumor regression.
2004
Pierre Coulie
Bernard Lethe
Christophe Lurquin
Aline Van Pel
Danièle Godelaine
Pierre van der Bruggen
Etienne De Plaen
Francis Brasseur
Catherine Germeau
Wenbin Ma
Kris Thielemans
Nicolas van Baren
Thierry Boon
Show All
Source
Cite
Save
Citations (0)
1